Refresh

Biocon Ltd.

Price on BSE   21 Jan,15:29 LIVE
365.00
-1.55
(-0.42%)

© 2026 Rediff.com
  • Volume :
  • 123,654.00
  • Prev Close :
  • 366.55
  • Day's H/L (Rs.) :
  • 370.00 - 359.05
  • 52wk H/L (Rs.) :
  • 424.95 - 290.80
  • Mkt Cap (Rs. Cr) :
  • 59,162.85
Price on NSE   21 Jan,15:59 LIVE
364.85
-2.00
(-0.55%)

© 2026 Rediff.com
  • Volume :
  • 2,608,596.00
  • Prev Close :
  • 366.85
  • Day's H/L (Rs.) :
  • 370.05 - 359.05
  • 52wk H/L (Rs.) :
  • 424.95 - 291.00
  • Mkt Cap (Rs. Cr) :
  • 0.00

View more

Market News

Biocon launches diabetes & obesity drugs in Netherlands
Rediff.com   16 Dec 2025
'We're 2 biggest fugitives': Lalit Modi, Mallya mock India
Rediff.com   24 Dec 2025
USFDA's new draft biosimilar rules to benefit Indian biotech cos
Rediff.com   09 Nov 2025
Report Card - Biocon Ltd.
PE Ratios
72.12
EPS (Rs.)
5.07
Sales (Rs. Cr)
583.30
Face Value (Rs.)
5
Net Profit Margin(%)
27.16
Last Bonus
1:1
Last Dividend(%)
10
Return on Average Equity
5.28

News for Biocon Ltd.

Syngene & Bristol Myers Squibb Extend Collaboration
Syngene International extends research collaboration with Bristol Myers Squibb through 2035, expanding drug development services.
Jan 19, 2026 18:18
Biocon Raises Rs 4,150 Cr via QIP Issue
Biocon raises Rs 4,150 crore through QIP. Funds to buy Mylan (Viatris) stake in Biocon Biologics. Focus on biosimilars, diabetes, oncology.
Jan 15, 2026 11:24
Biocon Gets USFDA Nod for Generic Everolimus Tablets
Biocon Pharma receives USFDA approval for generic Everolimus tablets, used to treat tuberous sclerosis complex (TSC).
Jan 12, 2026 13:43
Biocon Biologics: New Biosimilars for Cancer Treatment
Biocon Biologics to launch Trastuzumab, Nivolumab, Pembrolizumab biosimilars for cancer. Expanding oncology portfolio. Details here.
Jan 06, 2026 19:06
Biocon Licenses Diabetes Drug to Ajanta Pharma
Biocon out-licenses its diabetes drug Semaglutide to Ajanta Pharma for export to 23 countries in Africa, Middle East & Central Asia.
Dec 23, 2025 19:23

More News for Biocon Ltd. »

News for Pharmaceuticals and health care

Dalmia Bharat Q3 Profit Surges 94% to Rs 128 Cr
Dalmia Bharat Ltd reports 94% jump in Q3 profit to Rs 128 crore. Sales volume up, expenses down. Expansion plans on track. Details here.
Jan 21, 2026 19:38
6 GHz Spectrum Freed for Wi-Fi: Details Here
Govt de-licenses 500 MHz of 6 GHz spectrum to boost Wi-Fi. Learn about the impact on 5G, 6G, and the wireless ecosystem in India.
Jan 21, 2026 19:22
Karnataka Investment Talks at WEF Davos
Karnataka woos global firms at WEF Davos for investments in tech, energy, AI, manufacturing, and infrastructure projects.
Jan 21, 2026 19:10
Karnataka Investment Talks at WEF Davos
Karnataka woos global firms at WEF Davos for investments in tech, energy, AI, manufacturing, and infrastructure projects.
Jan 21, 2026 19:10
TN Govt & SanchiConnect Boost Deep Tech Startups
SanchiConnect partners with Tamil Nadu govt & iTNT to accelerate deep tech startup growth. Access mentorship, networks, markets & investors.
Jan 21, 2026 18:54

More News »

Top News

Dalmia Bharat Q3 Profit Surges 94% to Rs 128 Cr
Dalmia Bharat Ltd reports 94% jump in Q3 profit to Rs 128 crore. Sales volume up, expenses down. Expansion plans on track. Details here.
Jan 21, 2026 19:38
Piccadily Agro Q3 Profit Doubles to Rs 48 Cr
Piccadily Agro Industries reports a two-fold jump in net profit driven by its premium alcobev portfolio, including Indri whisky.
Jan 21, 2026 19:30
6 GHz Spectrum Freed for Wi-Fi: Details Here
Govt de-licenses 500 MHz of 6 GHz spectrum to boost Wi-Fi. Learn about the impact on 5G, 6G, and the wireless ecosystem in India.
Jan 21, 2026 19:22
Trump at Davos: Protests and Overflowing Rooms
Donald Trump addresses WEF in Davos amid protests. Venue overflows, many watch on phones. Security tight, slogans against climate, Iran & more.
Jan 21, 2026 19:19
Bank Unions Seek Mamata's Support on Strike
Bank unions seek Mamata Banerjee's support for a strike over the five-day banking week demand. Read the full story here.
Jan 21, 2026 19:16

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com